Senior insider sale
Chief Financial Officer at ORIC PHARMACEUTICALS, INC. — senior position signals high conviction
$3.10M
229.50K shares
What this filing means
PISCITELLI DOMINIC plans to sell 229.50K shares of ORIC PHARMACEUTICALS, INC. valued at approximately $3.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/26/2026ACC: 0001968582-26-000883
Officer· Chief Financial Officer
Since Apr 2020
229.50K
Shares to sell
$3.10M
Approx. market value
229.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Stock Option Exercise
Cash
8/26/2026
199.50KCompensation
NA
12/15/2025
2.23KCompensation
NA
12/15/2024
15.19KCompensation
NA
12/15/2023
8.76KCompensation
NA
12/15/2022
3.81KTotal acquired229.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/26/2026 | Stock Option Exercise Cash | 199.50K | — |
12/15/2025 | Compensation NA | 2.23K | — |
12/15/2024 | Compensation NA | 15.19K | — |
12/15/2023 | Compensation NA | 8.76K | — |
12/15/2022 | Compensation NA | 3.81K | — |
| Total | 229.50K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
229.50K
Market value
$3.10M
8/26/2026
Total
Units
229.50K
Value
$3.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/26/2026 | 229.50K | $3.10M | Nasdaq | Planned |
| Total | 229.50K | $3.10M | ||